Multi-Strain Probiotic Feed Additive for Clostridium perfringens Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for cost-effective probiotic strains and mixtures that can improve health and growth performance of beef cattle, particularly addressing clostridial diseases caused by Clostridium perfringens, which current treatments like antibiotics and vaccination are costly and only partially effective.

Innovation Solution

A novel combination of probiotic strains, including Lactobacillus animalis, Propionibacterium freudenreichii, Bacillus licheniformis, and Bacillus subtilis, is administered to beef cattle as a feed additive to inhibit Clostridium perfringens growth and enhance health and growth performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotics are used to treat pathogenic infections in livestock, then health improvement is achieved, but cost increases and antibiotic-resistant strains are generated

Engineering Contradiction:
Improvehealth improvementVSAvoidantibiotic-resistant strains
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent uses probiotic bacteria to convert the harmful effect of pathogenic bacteria into a beneficial outcome. The probiotics compete with pathogens for resources and space, producing beneficial substances like organic acids and bacteriocins that inhibit pathogen growth, thereby treating infections without using antibiotics and avoiding resistance development

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The probiotic strains act as an intermediary between the livestock's natural defenses and the pathogenic bacteria. These intermediary organisms establish a protective presence in the gastrointestinal tract, producing substances that mediate the inhibition of pathogen growth and preventing direct harmful interactions between pathogens and the animal host

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If antibiotics are used to prevent pathogenic infections, then disease prevention is achieved, but cost increases

Engineering Contradiction:
Improvedisease preventionVSAvoidcost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The probiotic system provides self-service disease prevention by establishing a persistent population of beneficial bacteria that continuously produce antimicrobial substances and compete with pathogens. This creates a self-sustaining protective mechanism that does not require repeated expensive antibiotic treatments, reducing overall cost while maintaining prevention efficacy

Inventive Principle:
Principle #25Self-service

3Productivity

If probiotic strains are used to improve health and growth performance, then productivity is improved, but the effectiveness against clostridial diseases is limited

Engineering Contradiction:
Improvegrowth performanceVSAvoideffectiveness against clostridial diseases
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent employs a composite probiotic formulation containing multiple bacterial strains (Bacillus subtilis, Lactobacillus animalis, Propionibacterium freudenreichii, and Bacillus licheniformis) with complementary mechanisms of action. This composite approach combines the spore-forming, heat-stable properties of Bacillus species with the acid-producing capabilities of Lactobacillus and Propionibacterium, creating a synergistic system that effectively addresses clostridial diseases while maintaining growth performance benefits

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20250312391A1A Mixture of Probiotic Strains to Improve Health and Growth Performance of Ruminants
Publication Date: 2025.10.09 CHR HANSEN AS
  • US20250312391A1 patent drawing
  • US20250312391A1 patent drawing
  • US20250312391A1 patent drawing

AI summary

The present disclosure generally relates to compositions and methods for inhibiting pathogenic growth, thereby reducing the severity of diarrhea episodes and also improving health and growth performance of ruminants. More specifically, the disclosure relates to compositions and methods for inhibiting pathogenic growth through the use of a novel combination of probiotic strains.